Patient Recruitment/Retention Featured Articles

  1. Why Is The Reality Of Patient Engagement Not Living Up To Its Theory? 9/17/2024

    Patient Co-Next's Pauline Frank discusses why pharma knows patient engagement is important but rarely succeeds in implementing it fully.

  2. If Sponsors Invite Patients To See The Final Draft Protocol, It's Already Too Late 9/17/2024

    Consultant Kamila Novak dives into the importance of early patient input — and why sponsors have a hard time getting it (and implementing it).

  3. Why Are We Still Excluding Persons With Disabilities (PWDs) In Clinical Trials? 9/13/2024

    Canary Advisors Cofounder and COO Richie Kahn details the National Council on Disability's call for the inclusion of people with disabilities in clinical trials.

  4. 4 Steps To Help Sponsors Return Individual Patient Data 9/10/2024

    In part two of this series on individual patient data return (iPDR), Legacy Health Strategies experts offer four steps to help sponsors make iPDR a reality.

  5. Returning Individual Trial Data To Patients: How And Why It Needs To Happen 9/9/2024

    Returning individual data to clinical trial participants is seen by many as "the right thing to do." Yet, its uptake is lacking. Legacy Health Strategies experts discuss why it's so important and how it can be achieved in part one of this two-part series.

  6. Which Top HEOR Trends Will Have The Biggest Impact On Clinical Research? 9/6/2024

    ISPOR CEO Rob Abbott discusses Health Economics and Outcomes Research (HEOR) trends and how they're impacting clinical trials. 

  7. Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy 9/5/2024

    Pelage Pharmaceuticals’ CMO Qing Yu Christina Weng, MD discusses how the company expanded criteria to include patients of all skin and hair types and incorporate decentralized elements in their trial design for a novel hair loss treatment.

  8. More Diverse Enrollment Means More Attention To I/E Language 9/4/2024

    Clinical research nurse Teri Crumb, MSN, RN, CCRC picks out a few potentially problematic inclusion/exclusion (I/E) criteria and details ways to address them.

  9. Navigating A Rare Disease Clinical Trial: A Patient And Family Perspective 9/3/2024

    Becky Vivian shares her inspiring story, offering readers valuable insights into the unique challenges faced by caregivers of rare disease patients.

  10. 3 Surefire Ways To Design Trials That Patients Want And Need 9/3/2024

     

    Alpha Tau Medical CMO Robert Den, MD details three ways sponsors can more effectively design clinical trials with patients in mind.